Sunshine Heart, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Sunshine Heart, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
http://www.priceseries.com/trade/CHFS-CHF-Solutions-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2018030220180320.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments